Review



prisma version 8.0 software program  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc prisma version 8.0 software program
    Prisma Version 8.0 Software Program, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prisma+software+version+8/prisma+software+version+8+0/pm36801466-62-27-32
    Average 90 stars, based on 1 article reviews
    prisma version 8.0 software program - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Standard Deviation:

    Article Title: Proteomic analysis of secreted proteins derived from amniotic fluid stem cells.
    Article Snippet: Data (the mean ± standard deviation; SD) were analyzed using Student’s t-test in PRISM software version 8.0 (GraphPad Software).

    Article Title: Reduced Survival and Resistance of Rhodotorula mucilaginosa Following Inhibition of Pigment Production by Naftifine.
    Article Snippet: Pigments produced by micro-organisms could contribute to their pathogenesis and resistance.. The investigation into the red pigment of R. mucilaginosa and its ability to survive and resist has not yet been explored.. This study aimed to investigate the survival and resistance of the R. mucilaginosa CQMU1 strain following inhibition of pigment production by naftifine and its underlying mechanism.

    Article Title: Determinants of Progression and Mortality in Lymphangioleiomyomatosis.
    Article Snippet: Using the progression cohort, we used a mixed-effects model with a random intercept and random slope to estimate the decline in FEV1 over time and used the PRISM version 8.0 software program (GraphPad) to visualize the results.

    Article Title: Caryophyllene Oxide, a Bicyclic Terpenoid Isolated from Annona macroprophyllata with Antitumor Activity: In Vivo, In Vitro, and In Silico Studies.
    Article Snippet: The results were analyzed using the GraphPad Prisma version 8.4 program (GraphPad software, San Diego, CA, USA).

    Article Title: Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
    Article Snippet: All statistical analyses were performed using the PRISM software (version 8.0; GraphPad Software, San Diego, CA).

    Article Title: Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy.
    Article Snippet: Immunotherapy has achieved prominent clinical efficacy in combating cancer and has recently become a mainstream treatment strategy.. However, achieving broad efficacy with a single modality is challenging, and the heterogeneity of the tumor microenvironment (TME) restricts the accuracy and effectiveness of immunotherapy strategies for tumors.. Herein, a TME-responsive targeted nanoparticle to enhance antitumor immunity and reverse immune escape by codelivering interleukin-12 (IL-12) expressing gene and colonystimulating factor-1 receptor (CSF-1R) inhibitor PLX3397 (PLX) is presented.


    Article Title: Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
    Article Snippet: Statistical analyses were performed by unpaired t-tests when two groups were analyzed using GraphPad PRISM version 8.0 software (GraphPad Software, La Jolla, CA, USA).

    Software:

    Article Title: Proteomic analysis of secreted proteins derived from amniotic fluid stem cells.
    Article Snippet: Data (the mean ± standard deviation; SD) were analyzed using Student’s t-test in PRISM software version 8.0 (GraphPad Software).

    Article Title: Reduced Survival and Resistance of Rhodotorula mucilaginosa Following Inhibition of Pigment Production by Naftifine.
    Article Snippet: Pigments produced by micro-organisms could contribute to their pathogenesis and resistance.. The investigation into the red pigment of R. mucilaginosa and its ability to survive and resist has not yet been explored.. This study aimed to investigate the survival and resistance of the R. mucilaginosa CQMU1 strain following inhibition of pigment production by naftifine and its underlying mechanism.

    Article Title: Determinants of Progression and Mortality in Lymphangioleiomyomatosis.
    Article Snippet: Using the progression cohort, we used a mixed-effects model with a random intercept and random slope to estimate the decline in FEV1 over time and used the PRISM version 8.0 software program (GraphPad) to visualize the results.

    Article Title: Caryophyllene Oxide, a Bicyclic Terpenoid Isolated from Annona macroprophyllata with Antitumor Activity: In Vivo, In Vitro, and In Silico Studies.
    Article Snippet: The results were analyzed using the GraphPad Prisma version 8.4 program (GraphPad software, San Diego, CA, USA).

    Article Title: Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
    Article Snippet: All statistical analyses were performed using the PRISM software (version 8.0; GraphPad Software, San Diego, CA).

    Article Title: Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy.
    Article Snippet: Immunotherapy has achieved prominent clinical efficacy in combating cancer and has recently become a mainstream treatment strategy.. However, achieving broad efficacy with a single modality is challenging, and the heterogeneity of the tumor microenvironment (TME) restricts the accuracy and effectiveness of immunotherapy strategies for tumors.. Herein, a TME-responsive targeted nanoparticle to enhance antitumor immunity and reverse immune escape by codelivering interleukin-12 (IL-12) expressing gene and colonystimulating factor-1 receptor (CSF-1R) inhibitor PLX3397 (PLX) is presented.


    Article Title: Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
    Article Snippet: Statistical analyses were performed by unpaired t-tests when two groups were analyzed using GraphPad PRISM version 8.0 software (GraphPad Software, La Jolla, CA, USA).



    Similar Products

    90
    GraphPad Software Inc prisma software version 8
    Prisma Software Version 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prisma+software+version+8/prism+software/pmc10631602__jasn___34___1889___s001-67-0-0
    Average 90 stars, based on 1 article reviews
    prisma software version 8 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc prisma software graphpad prism version 8
    Prisma Software Graphpad Prism Version 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prisma+software+version+8/graphpad+prism+software/pm40301689-503-9-11
    Average 90 stars, based on 1 article reviews
    prisma software graphpad prism version 8 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc prisma version 8 software
    Prisma Version 8 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prisma+software+version+8/prism+software/pm36610399-636-7-11
    Average 90 stars, based on 1 article reviews
    prisma version 8 software - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Dotmatics Limited prisma version 8 3.0 xlm software
    Prisma Version 8 3.0 Xlm Software, supplied by Dotmatics Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prisma+software+version+8/prisma+version+8+3+0+xlm+software/pmc09229490-233-5-7
    Average 90 stars, based on 1 article reviews
    prisma version 8 3.0 xlm software - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results